Buerger's disease or thromboangeitis obliterans;La maladie de Buerger ou thromboangeite obliterante

Revue de Medecine Interne

Volumn 19, Issue 1, 1998, Pages 34-43

  Reny, J L ^a   Cabane, J ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

Buerger's disease; Ischaemia; Superficial thrombophlebitis; Thromboangeitis obliterans; Tobacco

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ILOPROST; PROSTACYCLIN DERIVATIVE; STREPTOKINASE; VASODILATOR AGENT;

ADULT; AMPUTATION; ARTERIOGRAPHY; BUERGER DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; FEMALE; HUMAN; HYPERVOLEMIA; HYPOTHESIS; INTRAVENOUS DRUG ADMINISTRATION; LIMB ISCHEMIA; MALE; PATHOPHYSIOLOGY; PREVALENCE; REVASCULARIZATION; REVIEW; SEX DIFFERENCE; SMOKING; SYMPATHECTOMY; TOBACCO;

EID: 0031932182     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(97)83697-1     Document Type: Article

References (71)

1. 1 Lie JT, Mann RJ, Ludwig J. The brothers von Winiwarter, Alexander (1848-1917) and Felix (1852-1931), and thromboangeitis obliterans. Mayo Clin Proc 1979;54:802-7
2. 2 Buerger L. Thromboangeitis obliterans: a study of the vascular lesions leading to presenile spontaneous gangrene. Am J Med Sci 1908;136:567-80
3. 3 Buerger L. Classics thromboangeitis obliterans: A study of the vascular lesions leading to presenile spontaneous gangrene. Am J Med Sci 1973;266:278-91
4. 4 Wessler S, Ming SC, Gurewich V, Freiman DG. Critical evaluation of thromboangeitis obliterans: The case against Buerger's disease. N Engl J Med 1960;262:1149-60
5. 5 Barker NW. The case for retention of the diagnostic category "thromboangeitis obliterans". Circulation 1962;25:1-4
6. 6 Mc Kusick VA, Harris WS, Ottesen et al. Buerger's disease: a distinct clinical and pathologic entity. J Am Med Assoc 1962;181:93-100
7. 7 McPherson JR, Juergens JL, Gifford RW. Thromboangeitis obliterans and arteriosclerosis obliterans. Clinical and prognostic differences. Ann Intern Med 1963;59:288-96
8. 8 Schmidt C, Alan C, Schmitt J. Maladie de Buerger et artériopathies juvéniles. Essai de classification à partir d'une série de 127 cas. J Mal Vasc 1983;18:18-23
9. 9 Papa MZ, Rabi I, Adar R. A point scoring system for the clinical diagnostic of Buerger's disease. Eur J Endovasc Surg 1996;11:335-9
10. 10 Olin JW. Thromboangeitis obliterans. Curr Opin Rheumatol 1994;6:44-9
11. 11 Lie JT. Thromboangeitis obliterans (Buerger's disease) in women. Medicine 1986;65:65-72
12. 12 Remington PL, Forman MR, Gentry EM et al. Current smoking trends in the United States: The 1981-1983 behavior risk factor surveys. JAMA 1985;253:2975-8
13. 13 Grove WJ, Standsby JP. Buerger's disease in cigarette smoking in Bangladesh. Ann R Coll Surg Engl 1992;74:115-8
14. 14 Gindal RL. Buerger's disease in cigarette smoking in Bangladesh. Ann R Coll Surg Engl 1992;74:436-7
15. 15 Nielubowicz J, Rosnowski A, Pruszynski B et al. Natural history of Buerger's disease. J Cardiovasc Surg 1980;21:529-40
16. 16 Hagen B, Lohse S. Clinical and radiologic aspects of Buerger's disease. Cardiovasc Intervent Radiol 1984;7:283-93
17. 17 Dehaine-Bamberger N, Amar R, Touboul C et al. Maladie de Buerger, aspects cliniques et pronostiques. 83 observations. Presse Méd 1993;22:945-48
18. 18 Adar R, Papa MZ, Halpern Z et al. Cellular sensitivity to collagen in thromboangeitis obliterans. N Engl J Med 1983; 308:1113-6
19. 19 Shionoya S, Ban I, Nakata Y et al. Diagnosis, pathology, and treatment of Buerger's disease. Surgery 1974;75: 695-700
20. 20 Goodman RM, Elian B, Mozes M et al. Buerger's disease in Israel. Am J Med 1965;39:601-15
21. 21 Hill GL, Smith AH. Buerger's disease in Indonesia: Clinical course and prognostic factors. J Chron Dis 1974;27: 205-16
22. 22 Kinare SG, Kher YR, Rao G et al. Pattern of occlusive peripheral vascular disease in India. Angiology 1976;27: 165-80
23. 23 Nakata Y, Ban I, Hirai M et al. Onset and clinicopathological course in Buerger's disease. Angiology 1976;27:509-17
24. 24 Shionoya S, Hirai M, Kawai S et al. Pattern of arterial occlusion in Buerger's disease. Angiology 1982;33:375-84
25. 25 Olin JW, Young JR, Graor RA et al. The changing clinical spectrum of thromboangeitis obliterans (Buerger's disease). Circulation 1990;82(suppl IV):3-8
26. 26 Yorukoglu Y, Ilgit E, Zengin M et al. Thromboangeitis obliterans (Buerger's disease) in women (a reevaluation). Angiology 1993;44:527-32
27. 27 Stolley PD. Lung cancer in women:Five years later, situation worse. N Engl J Med 1983;308:428-9
28. 28 Juergens JL. Thromboangeitis obliterans (Buerger's disease, TAO). In: Juergens JL, Spittell JA Jr, Fairborn JF II, eds. Peripheral vascular diseases. Philadelphia: WB Saunders Co, 1980:467-91
29. 29 Lie JT. Thromboangeitis obliterans (Buerger's disease). Medicine 1987;66:65-72
30. 30 Fiessinger JN. Buerger's disease or thromboangeitis obliterans. In: Tooke JE, Lowe GDO eds. A textbook of vascular medicine. London: Arnold, 1996:275-86
31. 31 Mills JL, Taylor LM, Porter JM. Buerger's disease in the modern era. Am J Surg 1987;154:123-9
32. 32 Ohta T, Shionoya S. Fate of the ischaemic limb in Buerger's disease. Br J Surg 1988;75:259-62
33. 33 Hill GL, Moeliono J, Tumewu F et al. The Buerger syndrome in Java. A description and some aspect of its aetiology. Br J Surg 1973;60:606-13
34. 34 Hill GL, Moeliono J, Tumewu F et al. »Asian cigarette« is an adverse prognostic factor in peripheral arterial disease. Nature 1973;246:492-3
35. 35 Papa M, Bass A, Adar R et al. Autoimmune mechanisms in thromboangeitis obliterans (Buerger's disease): The role of tobacco antigen and the major histocompatibility complex. Surgery 1992;111:527-31
36. 36 Mc Laughlin GA, Helsby CR, Evans CC et al. Association of HLA-A9 and HLA-B5 with Buerger's Disease. Br Med J 1976;2:1165-6
37. 37 Ohtawa T, Takeo J, Kawwano N et al. HLA antigens in thromboangeitis obliterans. JAMA 1974;230:1128
38. 38 Schmitt J, Schmidt C, Alan C et al. Génétique des populations, bilan immunitaire et maladie de Buerger. Projection à travers une étude personnelle regroupant 127 cas d'artériopathies juvéniles. Bull Acad Natle Méd 1993;177:1153-64
39. 39 Aerbajinai W, Tsuchiya T, Kimura A et al. HLA class II DNA typing in Buerger's disease. Int J Cardiol 1996;54: S167-72
40. 40 Hada M, Sakihama T, Kamiya K et al. Cellular and humoral response to vascular components in thromboangeitis obliterans. Angiology 1993;44:533-40
41. 41 Casellas M, Pérez A, Cabero L et al. Buerger's disease and antiphospholipid antibodies in pregnancy. Ann Rheum Dis 1993;52:247-8
42. 42 Puèchal X, Job-Deslandre C, Menkès CJ, Fiessinger JN. Buerger's disease and antiphospholipid syndrome. Ann Rheum Dis 1993;52:766
43. 43 Pietraszek MH, Choudhury NA, Koyano K et al. Enhanced platelet response to serotonin in Buerger's disease. Thromb Res 1990;60:241-6
44. 44 Caramaschi P, Biasi D, Carletto A et al. A case of Buerger's disease with very high levels of lipoprotein(a). Clin Exp Rheumatol 1996;14:347-8
45. 45 Athanassiou P, McHale J, Dikeou S et al. Buerger's disease and protein S deficiency: successful treatment with prosta-cyclin. Clin Exp Rheumatol 1995;13:371-5
46. 46 Williams G. Recent views on Buerger's disease. J Clin Pathol 1969;22:573-8
47. 47 Bartolo M, Rulli F, Raffi S. Buerger's disease: Is it a rickettsiosis? Angiology 1980;31:660-5
48. 48 Rosencrance G, Thistlewaite T. Images in clinical medicine. thromboangeitis obliterans. N Engl J Med 1996; 334:891
49. 49 Schellongs SM, Bernhards J, Ensslen F et al. Intestinal type of thromboangeitis obliterans (Buerger's disease). J Intern Med 1994;235:69-73
50. 50 Harten P, Muller-Huelsbeck S, Regensburger D et al. Multiple organ manifestations in thromboangeitis obliterans (Buerger's disease). A case report. Angiology 1996;47:419-25
51. 51 Drake ME Jr. Winiwarter-Buerger's disease (thromboangeitis obliterans) with cerebral involvement. JAMA 1982; 248:1870-2
52. 52 Mautner GC, Mautner SL, Lin F et al. Amounts of coronary arterial narrowing and composition of material causing the narrowing in Buerger's disease. Am J Cardiol 1993;71:486-90
53. 53 Ferguson GT, Starkebaum G. Thromboangeitis obliterans associated with idiopathic hypereosinophilia. Arch Intern Med 1985;145:1726-8
54. 54 Lie JT, Michet CJ. Thromboangeitis obliterans with hypereosinophilia (Buerger's disease) of the temporal arteries. Hum Pathol 1988;19:598-602
55. 55 Genereau T, Wechsler B, Herson S et al. Temporal arteritis the syndrome vs Horton's arteritis the disease. J Rheumatol 1994;21:1980-1
56. 56 Lambotte O, Chazerain P, Vinciguerra C et al. Manifestations rhumatologiques de la maladie de Buerger. Rev Rhum 1997;64:357-61
57. 57 Zarnitsky C, Bravard P, Lévesque H et al. Maladie de Buerger révélée par des arthralgies, de la diarrhée et des nouures. Rev Rhum 1997;64:382-3
58. 58 Mozes M, Cahanski G, Doitsh V et al. The association of atherosclerosis and Buerger's disease: A clinical and radiological study. J Cardiovasc Surg 1970;11:52-9
59. 59 Hirai M, Shionoya S. Arterial obstruction of the upper limb in Buerger's disease: Its incidence and primary lesion. Br J Surg 1979;66:124-8
60. 60 Suzuki S, Yamada I, Himeno Y. Angiographic findings in Buerger's disease. Int J Cardiol 1996;54:S159-65
61. 61 Camilleri JP, Bruneval P. The vasculitis syndromes in aorta and large arteries. Pathological aspects. In: Camilleri JP, Berry CL, Fiessinger JN, Bariety J, eds. Diseases of the arterial wall. London: Springer-Verlag, 1989:457-82
62. 62 Adar R. Buerger's disease: The need for diagnostic criteria. Surgery 1974;76:848
63. 63 Cabane J. Thrombo-angéite oblitérante (maladie de Buerger). In: Godeau P, Piette JC, Herson S, éds. Traité de médecine. Paris: Flammarion Médecine Science, 1996:675-6
64. 64 Hofer-Mayer T, Adler RH, Minder C et al. Clinical speculation: Is specificity back? This time thromboangeitis obliterans. Psychosom Med 1995;57:195-201
65. 65 Hussein E, El Dorri A. Intra-arterial streptokinase as adjuvent therapy for complicated Buerger's disease: Early trials. Int Surg 1993;78:54-8
66. 66 Fiessinger JN, Schäfer M. Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangeitis obliterans. Lancet 1990;335:555-7
67. 67 Galley D, Rettori R, Boccalon H et al. La stimulation électrique médullaire dans les artériopathies des membres inférieurs. Une étude multicentrique chez 244 patients. J Mal Vasc 1992;17:208-13
68. 68 Jacobs MJ, J_rning PJ, Beckers RC et al. Foot salvage and improvement of microvascular blood flow as a result of epidural spinal cord electrical stimulation. J Vasc Surg 1990; 12:354-60
69. 69 Komori K, Kawasaki K, Okasaki J et al. Thoracoscopic sympathectomy for Buerger's disease of the upper extremities. J Vasc Surg 1995;22:344-6
70. 70 Laurian C, Brisset D, Gigou F et al. Revascularisation des artériopathies distales: une nouvelle approche. Presse Méd 1995;24:359-61
71. 71 Shionoya S. Buerger's disease: Diagnosis and management. Cardiovasc Surg 1993;1:207-14